Back to Search Start Over

The Effects of Long-term CPAP on Weight Change in Patients With Comorbid OSA and Cardiovascular Disease: Data From the SAVE Trial.

Authors :
Ou, Qiong
Chen, Baixin
Loffler, Kelly A.
Luo, Yuanming
Zhang, Xilong
Chen, Rui
Wang, Qian
Drager, Luciano F.
Lorenzi-Filho, Geraldo
Hlavac, Michael
McArdle, Nigel
Mukherjee, Sutapa
Mediano, Olga
Barbe, Ferran
Anderson, Craig S.
McEvoy, R. Doug
Woodman, Richard J.
SAVE investigators
Source :
CHEST; Apr2019, Vol. 155 Issue 4, p720-729, 10p
Publication Year :
2019

Abstract

<bold>Background: </bold>Although recent evidence suggests that OSA treatment may cause weight gain, the long-term effects of CPAP on weight are not well established.<bold>Methods: </bold>This study was a post hoc analysis of the Sleep Apnea Cardiovascular Endpoints (SAVE) study, a multicenter, randomized trial of CPAP plus standard care vs standard care alone in adults with a history of cardiac or cerebrovascular events and moderate to severe OSA. Participants with weight, BMI, and neck and waist circumferences measured at baseline and during follow-up were included. Linear mixed models were used to examine sex-specific temporal differences, and a sensitivity analysis compared high CPAP adherers (≥ 4 h per night) with propensity-matched control participants.<bold>Results: </bold>A total of 2,483 adults (1,248 in the CPAP group and 1,235 in the control group) were included (mean 6.1 ± 1.5 measures of weight available). After a mean follow-up of 3.78 years, there was no difference in weight change between the CPAP and control groups, for male subjects (mean [95% CI] between-group difference, 0.07 kg [-0.40 to 0.54]; P = .773) or female subjects (mean [95% CI] between-group difference, -0.14 kg [-0.37 to 0.09]; P = .233). Similarly, there were no significant differences in BMI or other anthropometric measures. Although male participants who used CPAP ≥ 4 h per night gained slightly more weight than matched male control subjects without CPAP (mean difference, 0.38 kg [95% CI, 0.04 to 0.73]; P = .031), there were no between-group differences in other anthropometric variables, nor were there any differences between female high CPAP adherers and matched control subjects.<bold>Conclusions: </bold>Long-term CPAP use in patients with comorbid OSA and cardiovascular disease does not result in clinically significant weight change.<bold>Trial Registry: </bold>ClinicalTrials.gov; No.: NCT00738179; URL: www.clinicaltrials.gov. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00123692
Volume :
155
Issue :
4
Database :
Complementary Index
Journal :
CHEST
Publication Type :
Academic Journal
Accession number :
135576369
Full Text :
https://doi.org/10.1016/j.chest.2018.08.1082